Clinical Trial Update: Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of piperacillin-tazobactam as empirical therapy for ventilator-associated pneumonia in ESBL-producing Enteroba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterobacteriaceae Infections
• Ventilator-associated Pneumonia

Drugs mentioned

• Piperacillin-tazobactam (Zosyn) (piperacillin/tazobactam)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Enterobacteriaceae Infections | NA | Status: COMPLETED